Stratify Prostate™ is a national initiative to provide
no-cost tumor sequencing and new clinical trial options
to 10,000 men with metastatic prostate cancer, with the
goal of broadening access and accelerating drug approvals. 

 

Conceived by leading physicians and researchers from UCSF Helen Diller Family Comprehensive Cancer Center and Strata Oncology, a precision oncology company.

 
 
 
UCSF_sig_navy_RGB.jpg
 

Picture1.png

FOR PATIENTS

Find out if you qualify for no-cost tumor sequencing through Stratify Prostate

 

Picture2.png

FOR PROVIDERS

 

 

We are seeking motivated physicians to join us

 


Stratify Prostate News